{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:02:11Z","timestamp":1793995331791,"version":"4.8.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s13555-022-00758-2","type":"journal-article","created":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T08:03:18Z","timestamp":1656662598000},"page":"1753-1775","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Update on the Management of Pediatric Psoriasis: An Italian Consensus"],"prefix":"10.1007","volume":"12","author":[{"given":"Ketty","family":"Peris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Belloni","family":"Fortina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Fabbrocini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Gisondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Balato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Bardazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Bernardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Bonamonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rita","family":"Bongiorno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Buligan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cusano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Beatrice De Felici","family":"Del Giudice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May","family":"El Hachem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Concetta","family":"Fargnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Gualdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Guarneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Hansel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Malara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Mazzatenta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Micali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Narcisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iria","family":"Neri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Oranges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Panzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"Parodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Restano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriana","family":"Simonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Venturini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8961-7108","authenticated-orcid":false,"given":"Vito","family":"Di Lernia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,1]]},"reference":[{"issue":"1","key":"758_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.2174\/1573400511666150504125456","volume":"11","author":"M Megna","year":"2015","unstructured":"Megna M, Napolitano M, Balato A, et al. Psoriasis in children: a review. Curr Pediatr Rev. 2015;11(1):10\u201326.","journal-title":"Curr Pediatr Rev"},{"issue":"10281","key":"758_CR2","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker JNWN. Psoriasis. Lancet. 2021;397(10281):1301\u201315.","journal-title":"Lancet"},{"key":"758_CR3","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s40272-015-0137-1","volume":"17","author":"IMGJ Bronckers","year":"2015","unstructured":"Bronckers IMGJ, Paller AS, van Geel MJ, van de Kerkhof PCM, Seyger MMB. Psoriasis in children and adolescents: diagnosis, management and comorbidities. Pediatr Drugs. 2015;17:373\u201384.","journal-title":"Pediatr Drugs"},{"issue":"12","key":"758_CR4","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1001\/archderm.141.12.1537","volume":"141","author":"JM Gelfand","year":"2005","unstructured":"Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol. 2005;141(12):1537\u201341.","journal-title":"Arch Dermatol"},{"issue":"5","key":"758_CR5","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1080\/09546630902911847","volume":"20","author":"MEA De Jager","year":"2009","unstructured":"De Jager MEA, van de Kerkhof PCM, De Jong EMGJ, Seyger MMB. Epidemiology and prescribed treatments in childhood psoriasis: a survey among medical professionals. J Dermatol Treat. 2009;20(5):254\u20138.","journal-title":"J Dermatol Treat"},{"issue":"3","key":"758_CR6","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/j.1365-2133.2009.09593.x","volume":"162","author":"M Augustin","year":"2010","unstructured":"Augustin M, Glaeske G, Radtke MA, Christophers E, Reich K, Schafer I. Epidemiology and comorbidity of psoriasis in children. Br J Dermatol. 2010;162(3):633\u20136.","journal-title":"Br J Dermatol"},{"issue":"1","key":"758_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000381913","volume":"231","author":"M Augustin","year":"2015","unstructured":"Augustin M, Radtke MA, Glaeske G, et al. Epidemiology and comorbidity in children with psoriasis and atopic eczema. Dermatology. 2015;231(1):35\u201340.","journal-title":"Dermatology"},{"issue":"8","key":"758_CR8","first-page":"856","volume":"17","author":"L Eisert","year":"2019","unstructured":"Eisert L, Augustin M, Bach S, et al. S2k guidelines for the treatment of psoriasis in children and adolescents\u2014short version part 1. J Dtsch Dermatol Ges. 2019;17(8):856\u201370.","journal-title":"J Dtsch Dermatol Ges"},{"issue":"3","key":"758_CR9","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1046\/j.1525-1470.2001.018003188.x","volume":"18","author":"A Morris","year":"2001","unstructured":"Morris A, Rogers M, Fischer G, Williams K. Childhood psoriasis: a clinical review of 1262 cases. Pediatr Dermatol. 2001;18(3):188\u201398.","journal-title":"Pediatr Dermatol"},{"issue":"7","key":"758_CR10","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1001\/jamadermatol.2017.0499","volume":"153","author":"E Osier","year":"2017","unstructured":"Osier E, Wang AS, Tollefson MM, et al. Pediatric psoriasis comorbidity screening guidelines. JAMA Dermatol. 2017;153(7):698\u2013704.","journal-title":"JAMA Dermatol"},{"issue":"2","key":"758_CR11","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/bjd.15095","volume":"177","author":"T Todberg","year":"2017","unstructured":"Todberg T, Egeberg A, Jensen P, Gislason G, Skov L. Psychiatric comorbidities in children and adolescents with psoriasis: a population-based cohort study. Br J Dermatol. 2017;177(2):551\u20133.","journal-title":"Br J Dermatol"},{"key":"758_CR12","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/pde.13772","volume":"36","author":"AS Paller","year":"2019","unstructured":"Paller AS, Schenfeld J, Accortt NA, Kricorian G. A retrospective cohort study to evaluate the development of comorbidities, including psychiatric comorbidities, among a pediatric psoriasis population. Pediatric Dermatol. 2019;36:290\u20137.","journal-title":"Pediatric Dermatol"},{"issue":"7","key":"758_CR13","doi-asserted-by":"publisher","first-page":"3948","DOI":"10.1007\/s12325-021-01795-7","volume":"38","author":"E Edson-Heredia","year":"2021","unstructured":"Edson-Heredia E, Anderson S, Guo J, et al. Real-world claims analysis of comorbidity burden, treatment pattern, healthcare resource utilization, and costs in pediatric psoriasis. Adv Ther. 2021;38(7):3948\u201361.","journal-title":"Adv Ther"},{"issue":"6","key":"758_CR14","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1111\/j.1525-1470.2011.01489.x","volume":"28","author":"ME de Jager","year":"2011","unstructured":"de Jager ME, De Jong EM, Evers AW, Van De Kerkhof PC, Seyger MM. The burden of childhood psoriasis. Pediatr Dermatol. 2011;28(6):736\u20137.","journal-title":"Pediatr Dermatol"},{"key":"758_CR15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3390\/children6120133","volume":"6","author":"CH Na","year":"2019","unstructured":"Na CH, Chung J, Simpson EL. Quality of life and disease impact of atopic dermatitis and psoriasis on children and their families. Children. 2019;6:133.","journal-title":"Children"},{"issue":"3","key":"758_CR16","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00431-011-1587-2","volume":"171","author":"JW Varni","year":"2012","unstructured":"Varni JW, Globe DR, Gandra SR, Harrison DJ, Hooper M, Baumgartner S. Health-related quality of life of pediatric patients with moderate to severe plaque psoriasis: comparisons to four common chronic diseases. Eur J Pediatr. 2012;171(3):485\u201392.","journal-title":"Eur J Pediatr"},{"issue":"2","key":"758_CR17","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jaad.2016.09.014","volume":"76","author":"MM Tollefson","year":"2017","unstructured":"Tollefson MM, Finnie DM, Schoch JJ, Eton DT. Impact of childhood psoriasis on parents of affected children. J Am Acad Dermatol. 2017;76(2):286\u20139.","journal-title":"J Am Acad Dermatol"},{"key":"758_CR18","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s13555-016-0117-6","volume":"6","author":"M Napolitano","year":"2016","unstructured":"Napolitano M, Megna M, Balato A, et al. Systemic treatment of pediatric psoriasis: a review. Dermatol Ther. 2016;6:125\u201342.","journal-title":"Dermatol Ther"},{"issue":"10","key":"758_CR19","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s00431-017-2985-x","volume":"176","author":"A Belloni Fortina","year":"2017","unstructured":"Belloni Fortina A, Bardazzi F, Berti S, et al. Treatment of severe psoriasis in children: recommendations of an Italian expert group. Eur J Pediatr. 2017;176(10):1339\u201354.","journal-title":"Eur J Pediatr"},{"issue":"9","key":"758_CR20","first-page":"959","volume":"17","author":"L Eisert","year":"2019","unstructured":"Eisert L, Augustin M, Bach S, et al. S2k guidelines for the treatment of psoriasis in children and adolescents\u2014short version part 2. J Dtsch Dermatol Ges. 2019;17(9):959\u201374.","journal-title":"J Dtsch Dermatol Ges"},{"key":"758_CR21","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jaad.2019.08.049","volume":"82","author":"A Menter","year":"2020","unstructured":"Menter A, Cordoro KM, Davis DMR, et al. Joint American Academy of Dermatology\u2014National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients. J Am Acad Dermatol. 2020;82:161\u2013201.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"758_CR22","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1046\/j.1365-2648.2000.t01-1-01567.x","volume":"32","author":"F Hasson","year":"2000","unstructured":"Hasson F, Keeney S, McKenna H. Research guidelines for the Delphi survey technique. J Adv Nurs. 2000;32(4):1008\u201315.","journal-title":"J Adv Nurs"},{"key":"758_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0022-3999(00)00210-5","volume":"50","author":"H Richards","year":"2001","unstructured":"Richards H, Fortune D, Griffiths C, Main C. The contribution of perceptions of stigmatisation to disability in patients with psoriasis. J Psychosom Res. 2001;50:11\u20135.","journal-title":"J Psychosom Res"},{"issue":"3","key":"758_CR24","first-page":"374","volume":"156","author":"F Caroppo","year":"2021","unstructured":"Caroppo F, Zacchino M, Milazzo E, et al. Quality of life in children with psoriasis: results from a monocentric study. Ital J Dermatol Venerol. 2021;156(3):374\u20137.","journal-title":"Ital J Dermatol Venerol"},{"issue":"6","key":"758_CR25","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1111\/j.1365-2133.1995.tb16953.x","volume":"132","author":"MS Lewis-Jones","year":"1995","unstructured":"Lewis-Jones MS, Finlay AY. The Children\u2019s Dermatology Life Quality Index (CDLQI): initial validation and practical use. Br J Dermatol. 1995;132(6):942\u20139.","journal-title":"Br J Dermatol"},{"issue":"5","key":"758_CR26","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1111\/j.1365-2133.2010.09993.x","volume":"163","author":"ME de Jager","year":"2010","unstructured":"de Jager ME, van de Kerkhof PC, de Jong EM, Seyger MM. A cross- sectional study using the Children\u2019s Dermatology Life Quality Index (CDLQI) in childhood psoriasis: negative effect on quality of life and moderate correlation of CDLQI with severity scores. Br J Dermatol. 2010;163(5):1099\u2013101.","journal-title":"Br J Dermatol"},{"issue":"2","key":"758_CR27","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1046\/j.1365-2133.2003.05157.x","volume":"148","author":"SA Holme","year":"2003","unstructured":"Holme SA, Man I, Sharpe JL, Dykes PJ, Lewis-Jones MS, Finlay AY. The Children\u2019s Dermatology Life Quality Index: validation of the cartoon version. Br J Dermatol. 2003;148(2):285\u201390.","journal-title":"Br J Dermatol"},{"issue":"3","key":"758_CR28","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.jaci.2011.05.003","volume":"128","author":"MJ Slattery","year":"2011","unstructured":"Slattery MJ, Essex MJ, Paletz EM, et al. Depression, anxiety, and dermatologic quality of life in adolescents with atopic dermatitis. J Allergy Clin Immunol. 2011;128(3):668\u201371.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"758_CR29","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/bjd.12437","volume":"169","author":"MS Salek","year":"2013","unstructured":"Salek MS, Jung S, Brincat-Ruffini LA, et al. Clinical experience and psychometric properties of the Children\u2019s Dermatology Life Quality Index (CDLQI), 1995\u20132012. Br J Dermatol. 2013;169(4):734\u201359.","journal-title":"Br J Dermatol"},{"key":"758_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00403-010-1080-1","volume":"303","author":"U Mrowietz","year":"2011","unstructured":"Mrowietz U, Kragballe K, Reich K, et al. Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch Dermatol Res. 2011;303:1\u201310.","journal-title":"Arch Dermatol Res"},{"issue":"2","key":"758_CR31","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3109\/09546634.2014.880396","volume":"26","author":"G Girolomoni","year":"2015","unstructured":"Girolomoni G, Griffiths CEM, Krueger J, et al. Early intervention in psoriasis and immune-mediated inflammatory diseases: a hypothesis paper. J Dermatol Treat. 2015;26(2):103\u201312.","journal-title":"J Dermatol Treat"},{"key":"758_CR32","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/bjd.18245","volume":"182","author":"NJ Korman","year":"2020","unstructured":"Korman NJ. Management of psoriasis as a systemic disease: what is the evidence? Br J Dermatol. 2020;182:840\u20138.","journal-title":"Br J Dermatol"},{"key":"758_CR33","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1136\/annrheumdis-2012-202646","volume":"73","author":"IB McInnes","year":"2014","unstructured":"McInnes IB, Sieper J, Braun J, et al. Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof of concept trial. Ann Rheum Dis. 2014;73:349\u201356.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"758_CR34","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s13075-019-1957-0","volume":"21","author":"E Kampylafka","year":"2019","unstructured":"Kampylafka E, Simon D, d\u2019Oliveira I, et al. Disease interception with interleukin-17 inhibition in high-risk psoriasis patients with subclinical joint inflammation\u2014data from the prospective IVEPSA study. Arthritis Res Ther. 2019;21(1):178.","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"758_CR35","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1002\/art.40778","volume":"71","author":"L Savage","year":"2019","unstructured":"Savage L, Goodfield M, Horton L, et al. Regression of peripheral subclinical enthesopathy in therapy-na\u00efve patients treated with ustekinumab for moderate-to-severe chronic plaque psoriasis: a fifty-two-week prospective, open-label feasibility study. Arthritis Rheumatol. 2019;71(4):626\u201331.","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"758_CR36","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1684\/ejd.2016.2785","volume":"26","author":"MJ Van Geel","year":"2016","unstructured":"Van Geel MJ, Spillekom-Van Kouli S, Oostveen AM, et al. An outpatient multidisciplinary training programme for children and adolescents with psoriasis and their parents: a pilot study. Eur J Dermatol. 2016;26(4):393\u20135.","journal-title":"Eur J Dermatol"},{"key":"758_CR37","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1136\/bmj.332.7547.933","volume":"332","author":"D Staub","year":"2006","unstructured":"Staub D, Diepgen L, Fartasch M, et al. Age related, structured educational programmes for the management of atopic dermatitis in children and adolescents: multicentre, randomized controlled trial. BMJ. 2006;332:933\u20138.","journal-title":"BMJ"},{"key":"758_CR38","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1136\/bmj.332.7547.923","volume":"332","author":"HC Williams","year":"2006","unstructured":"Williams HC. Educational programmes for young people with eczema. One size does not fit all. BMJ. 2006;332:923\u20134.","journal-title":"BMJ"},{"issue":"1","key":"758_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1525-1470.2008.00813.x","volume":"26","author":"G Ricci","year":"2009","unstructured":"Ricci G, Bendandi B, Aiazzi R, Patrizi A, Masi M. Three years of Italian experience of an educational program for parents of young children affected by atopic dermatitis: improving knowledge produces lower anxiety levels in parents of children with atopic dermatitis. Pediatr Dermatol. 2009;26(1):1\u20135.","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"758_CR40","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/pde.12045","volume":"30","author":"S Barbarot","year":"2013","unstructured":"Barbarot S, Bernier S, Deleuran M, et al. Oriented patient-education network in dermatology. Therapeutic patient education in children with atopic dermatitis: position paper on objectives and recommendations. Pediatr Dermatol. 2013;30(2):199\u2013206.","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"758_CR41","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3109\/09546634.2012.672707","volume":"24","author":"AM Oostveen","year":"2013","unstructured":"Oostveen AM, Spillekom-van Koulil S, Otero ME, Klompmaker W, Evers AWM, Seyger MMB. Development and design of a multidisciplinary training program for outpatient children and adolescents with psoriasis and their parents. J Dermatol Treat. 2013;24(1):60\u20133.","journal-title":"J Dermatol Treat"},{"key":"758_CR42","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/j.jaad.2021.07.054","volume":"85","author":"S Wack","year":"2021","unstructured":"Wack S, Patton T, Ferris L. COVID-19 vaccine safety and efficacy in patients with immune-mediated inflammatory disease: review of available evidence. J Am Acad Dermatol. 2021;85:1274\u201384.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"758_CR43","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00403-020-02145-3","volume":"313","author":"J Beer","year":"2021","unstructured":"Beer J, Hadeler E, Calume A, Gitlow H, Nouri K. Teledermatology: current indications and considerations for future use. Arch Dermatol Res. 2021;313(1):11\u20135.","journal-title":"Arch Dermatol Res"},{"key":"758_CR44","unstructured":"Ministero della Salute. Indicazioni Nazionali per l\u2019erogazione di prestazioni di telemedicina. 27 Oct 2020. Versione 4.4. https:\/\/www.quotidianosanita.it\/allegati\/allegato2602365.pdf. Accessed Mar 2022."},{"issue":"6","key":"758_CR45","doi-asserted-by":"publisher","first-page":"e183062","DOI":"10.1001\/jamanetworkopen.2018.3062","volume":"1","author":"AW Armstrong","year":"2018","unstructured":"Armstrong AW, Chambers CJ, Maverakis E, et al. Effectiveness of online vs in-person care for adults with psoriasis. A randomized clinical trial. JAMA Netw Open. 2018;1(6):e183062.","journal-title":"JAMA Netw Open"},{"issue":"5","key":"758_CR46","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.jid.2018.09.039","volume":"139","author":"AW Armstrong","year":"2019","unstructured":"Armstrong AW, Ford AR, Chambers CJ, et al. Online care versus in-person care for improving quality of life in psoriasis: a randomized controlled equivalency trial. J Investig Dermatol. 2019;139(5):1037\u201344.","journal-title":"J Investig Dermatol"},{"issue":"6","key":"758_CR47","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13908","volume":"33","author":"A Dahy","year":"2020","unstructured":"Dahy A, El-Qushavri AE, Mahmoud AR, Mahmoud AR, Al-Kelany TA, Salman S. Telemedicine approach for psoriasis management, time for application? A systematic review of published studies. Dermatol Ther. 2020;33(6): e13908.","journal-title":"Dermatol Ther"},{"key":"758_CR48","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s13555-021-00555-3","volume":"11","author":"P Gisondi","year":"2021","unstructured":"Gisondi P, Bellinato F, Piaserico S, Di Leo S, Cazzaniga S, Naldi L. Preference for telemedicine versus in-person visit among patients with psoriasis receiving biological drugs. Dermatol Ther. 2021;11:1333\u201343.","journal-title":"Dermatol Ther"},{"key":"758_CR49","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.annder.2021.01.005","volume":"148","author":"Q Beytout","year":"2021","unstructured":"Beytout Q, Pepiot J, Maruani A, et al. Impact of the COVID-19 pandemic on children with psoriasis. Ann Dermatolog V\u00e9n\u00e9r\u00e9log. 2021;148:106\u201311.","journal-title":"Ann Dermatolog V\u00e9n\u00e9r\u00e9log"},{"issue":"6 Pt 2","key":"758_CR50","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/0190-9622(91)70319-W","volume":"25","author":"G Herz","year":"1991","unstructured":"Herz G, Blum G, Yawalkar S. Halobetasol propionate cream by day and halobetasol propionate ointment at night for the treatment of pediatric patients with chronic, localized plaque psoriasis and atopic dermatitis. J Am Acad Dermatol. 1991;25(6 Pt 2):1166\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"758_CR51","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1517\/14656566.9.11.2001","volume":"9","author":"JE Frangos","year":"2008","unstructured":"Frangos JE, Kimball AB. Clobetasol propionate emollient formulation foam in the treatment of corticosteroid-responsive dermatoses. Expert Opin Pharmacother. 2008;9(11):2001\u20137.","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"758_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2005.01.010","volume":"54","author":"UR Hengge","year":"2006","unstructured":"Hengge UR, Ruzicka T, Schwartz RA, Cork MJ. Adverse effects of topical glucocorticoids. J Am Acad Dermatol. 2006;54(1):1\u201315.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"758_CR53","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/pde.13042","volume":"34","author":"V Di Lernia","year":"2017","unstructured":"Di Lernia V, Neri I. Clobetasol, acitretin, and Cushing\u2019s syndrome. Pediatr Dermatol. 2017;34(2):221.","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"758_CR54","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.jaad.2009.06.048","volume":"62","author":"ME de Jager","year":"2010","unstructured":"de Jager ME, de Jong EM, van de Kerkhof PC, Seyger MM. Efficacy and safety of treatments for childhood psoriasis: a systematic literature review. J Am Acad Dermatol. 2010;62(6):1013\u201330.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"758_CR55","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/pde.12429","volume":"32","author":"LF Eichenfield","year":"2015","unstructured":"Eichenfield LF, Ganslandt C, Kurvits M, Schlessinger J. Safety and efficacy of calcipotriene plus betamethasone dipropionate topical suspension in the treatment of extensive scalp psoriasis in adolescents ages 12 to 17 years. Pediatr Dermatol. 2015;32(1):28\u201335.","journal-title":"Pediatr Dermatol"},{"key":"758_CR56","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1525-1470.2007.00341.x","volume":"24","author":"A Brune","year":"2007","unstructured":"Brune A, Miller DW, Lin P, Cotrim-Russi D, Paller AS. Tacrolimus ointment is effective for psoriasis on the face and intertriginous areas in pediatric patients. Pediatr Dermatol. 2007;24:76\u201380.","journal-title":"Pediatr Dermatol"},{"key":"758_CR57","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.jaad.2005.05.036","volume":"53","author":"JA Steele","year":"2005","unstructured":"Steele JA, Choi C, Kwong PC. Topical tacrolimus in the treatment of inverse psoriasis in children. J Am Acad Dermatol. 2005;53:713\u20136.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"758_CR58","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1525-1470.2008.00773.x","volume":"25","author":"S Ersoy-Evans","year":"2008","unstructured":"Ersoy-Evans S, Altaykan A, Sahin S, Kolemen F. Phototherapy in childhood. Pediatr Dermatol. 2008;25(6):599\u2013605.","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"758_CR59","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/j.1468-3083.2010.03832.x","volume":"25","author":"M Pavlovsky","year":"2011","unstructured":"Pavlovsky M, Baum S, Shpiro D, Pavlovsky L, Pavlotsky F. Narrow band UVB: is it effective and safe for paediatric psoriasis and atopic dermatitis? J Eur Acad Dermatol Venereol. 2011;25(6):727\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"758_CR60","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/phpp.12604","volume":"37","author":"E Seccombe","year":"2021","unstructured":"Seccombe E, Wynne MD, Clancy C, Godfrey KM, Fityan A. A retrospective review of phototherapy in children, at a tertiary paediatric unit. Photodermatol Photoimmunol Photomed. 2021;37(1):34\u20138.","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"5","key":"758_CR61","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/j.1525-1470.2008.00729.x","volume":"25","author":"VK Jain","year":"2008","unstructured":"Jain VK, Bansal A, Aggarwal K, Jain K. Enhanced response of childhood psoriasis to narrow-band UV-B phototherapy with preirradiation use of mineral oil. Pediatr Dermatol. 2008;25(5):559\u201364.","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"758_CR62","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1056\/NEJMoa066886","volume":"358","author":"AS Paller","year":"2008","unstructured":"Paller AS, Siegfried EC, Langley RG, et al. Etanercept treatment for children and adolescents with plaque psoriasis. N Engl J Med. 2008;358(3):241\u201351.","journal-title":"N Engl J Med"},{"issue":"2","key":"758_CR63","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jaad.2015.09.056","volume":"74","author":"AS Paller","year":"2016","unstructured":"Paller AS, Siegfried EC, Pariser DM, et al. Long-term safety and efficacy of etanercept in children and adolescents with plaque psoriasis. J Am Acad Dermatol. 2016;74(2):280\u20137.","journal-title":"J Am Acad Dermatol"},{"issue":"10089","key":"758_CR64","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0140-6736(17)31189-3","volume":"390","author":"K Papp","year":"2017","unstructured":"Papp K, Thaci D, Marcoux D, et al. Efficacy and safety of adalimumab every other week versus methotrexate once weekly in children and adolescents with severe chronic plaque psoriasis: a randomised, double-blind, phase 3 trial. Lancet. 2017;390(10089):40\u20139.","journal-title":"Lancet"},{"issue":"4","key":"758_CR65","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.jaad.2015.07.002","volume":"73","author":"I Landells","year":"2015","unstructured":"Landells I, Marano C, Hsu MC, et al. Ustekinumab in adolescent patients age 12 to 17 years with moderate-to-severe plaque psoriasis: results of the randomized phase 3 CADMUS study. J Am Acad Dermatol. 2015;73(4):594\u2013603.","journal-title":"J Am Acad Dermatol"},{"key":"758_CR66","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1111\/bjd.18029","volume":"181","author":"D Thaci","year":"2019","unstructured":"Thaci D, Papp K, Marcoux D, et al. Sustained long-term efficacy and safety of adalimumab in paediatric patients with severe chronic plaque psoriasis from a randomized, double-blind, phase III study. Br J Dermatol. 2019;181:1177\u201389.","journal-title":"Br J Dermatol"},{"key":"758_CR67","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/bjd.19147","volume":"183","author":"AS Paller","year":"2020","unstructured":"Paller AS, Seyger MMB, Alejandro Magarinos G, et al. Efficacy and safety of ixekizumab in a phase III, randomized, double-blind, placebo-controlled study in paediatric patients with moderate-to-severe plaque psoriasis (IXORA-PEDS). Br J Dermatol. 2020;183:231\u201341.","journal-title":"Br J Dermatol"},{"key":"758_CR68","first-page":"938","volume":"35","author":"C Bodemer","year":"2021","unstructured":"Bodemer C, Kaszuba A, Kingo K, et al. Secukinumab demonstrates high efficacy and a favourable safety profile in paediatric patients with severe chronic plaque psoriasis: 52-week results from a phase 3 double-blind randomized, controlled trial. JEADV. 2021;35:938\u201347.","journal-title":"JEADV"},{"issue":"5","key":"758_CR69","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3109\/09546634.2015.1120852","volume":"27","author":"V Di Lernia","year":"2016","unstructured":"Di Lernia V, Stingeni L, Boccaletti V, et al. Effectiveness and safety of cyclosporine in pediatric plaque psoriasis: a multicentric retrospective analysis. J Dermatol Treat. 2016;27(5):395\u20138.","journal-title":"J Dermatol Treat"},{"issue":"5","key":"758_CR70","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/pde.12940","volume":"33","author":"V Di Lernia","year":"2016","unstructured":"Di Lernia V, Bonamonte D, Lasagni C, et al. Effectiveness and safety of acitretin in children with plaque psoriasis: a multicenter retrospective analysis. Pediatr Dermatol. 2016;33(5):530\u20135.","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"758_CR71","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s40257-021-00603-w","volume":"22","author":"A Thatiparthi","year":"2021","unstructured":"Thatiparthi A, Martin A, Liu J, Egeberg A, Wu JJ. Biologic treatment algorithms for moderate-to-severe psoriasis with comorbid conditions and special populations: a review. Am J Clin Dermatol. 2021;22(4):425\u201342.","journal-title":"Am J Clin Dermatol"},{"key":"758_CR72","unstructured":"FDA label of combination calcipotriol-betamethasone dipropionate (Enstilar\u00ae foam). https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/207589s005s006s007lbl.pdf. Accessed Mar 2022."},{"key":"758_CR73","unstructured":"Adalimumab. EMA summary of product characteristics. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/humira-epar-product-information_en.pdf. Accessed Mar 2022."},{"key":"758_CR74","unstructured":"Ixekizumab. EMA summary of product characteristics. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/taltz-epar-product-information_en.pdf. Accessed Mar 2022."},{"key":"758_CR75","unstructured":"Secukinumab. EMA summary of product characteristics. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/cosentyx-epar-product-information_en.pdf. Accessed Mar 2022."},{"key":"758_CR76","unstructured":"Etanercept. EMA summary of product characteristics. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/enbrel-epar-product-information_en.pdf. Accessed Mar 2022."},{"key":"758_CR77","unstructured":"Ustekinumab. EMA summary of product characteristics. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/stelara-epar-product-information_en.pdf. Accessed Mar 2022."}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-022-00758-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-022-00758-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-022-00758-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T01:13:15Z","timestamp":1700788395000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-022-00758-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,1]]},"references-count":77,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["758"],"URL":"https:\/\/doi.org\/10.1007\/s13555-022-00758-2","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,1]]},"assertion":[{"value":"29 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Given name\\Family name of author May El Hachem updated","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}]}}